Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
NCT ID: NCT05867173
Last Updated: 2025-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2022-09-16
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cochlear Implant Speech in Noise Processing
NCT06860152
Cochlear Implants and Listening Effort: the Interaction of Cognitive and Sensory Constraints
NCT07279441
Speech Perception for Children With Cochlear Implants
NCT01059838
Investigation of Anatomical Correlates of Speech Discrimination
NCT01781039
Cochlear Implant Speech and Non-speech Sound Recognition
NCT03661970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Performance Assessed with Experimental Sound Processing Strategy
Patients listening to experimental cochlear implant processing strategy.
Experimental Speech Processing Strategy
Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.
Control
Patients listening to their clinical cochlear implant using their "own" processor (their everyday listening situation).
No interventions assigned to this group
Experimental Control
Patients listening to experimental cochlear implant using a processing strategy like thier clinical program, a "clinical like" program.
Experimental Speech Processing Strategy
Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental Speech Processing Strategy
Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Native speakers of American English
* Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL
* Children at least 3 months old
* Native speakers of American English
* Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL
* For both children and adults with a cochlear implant, some study criteria might pertain to a subset of subjects, such as a specific age at which the subjects developed a hearing loss, or was implanted.
* Unable to carry out the study protocol or tasks required in the study
Exclusion for all Normal Hearing Subjects:
* Inability to provide informed consent
* Hearing loss, or significant history of hearing related issues
* Unable to carry out the study protocol or tasks required in the study
Exclusion Criteria
* Inability to provide informed consent
3 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts Eye and Ear Infirmary
OTHER
Boston Children's Hospital
OTHER
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julie G. Arenberg, CCC-A
Director of Research and Education
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie Arenberg
Role: PRINCIPAL_INVESTIGATOR
Massachusetts Eye and Ear
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mass Eye and Ear
Boston, Massachusetts, United States
Boston Children's Hospital
Waltham, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MGB_2019P000239
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.